Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content

Abstract

GDP are rapidly absorbed from the peritoneal cavity. Administration of PD solutions with low-GDP content reduces plasma AGE levels and may thus improve the cardiovascular risk profile of dialysed children.